LITTLE FALLS, NJ – February 21, 2007 - Sentrx, a leading provider of technology-enabled solutions for global drug safety, announced today that it is an implementer in one of five interoperability scenarios to be demonstrated at the upcoming Healthcare Information Management Systems Society’s Annual Conference and Exhibition, known as HIMSS’07. Sentrx is contributing its expertise in drug safety data and pharmacovigilance systems to help demonstrate a patient-reported adverse event transferring from the physician’s practice system to the pharmaceutical company’s safety system using industry standards.

At HIMSS’07, the Interoperability Showcase will transport attendees through real-world clinical scenarios enabled by standards-based solutions. The Clinical Data Interchange Standards Consortium (CDISC) and Integrating the Healthcare Enterprise (IHE), two standards bodies within the healthcare information spectrum, are leading the prototype of bridging healthcare data to pharmaceutical research and surveillance.

The New Directions - Life Sciences Interoperability Demonstration includes five case scenarios depicting clinical data transferring seamlessly between care provider’s electronic health record (EHR) systems and systems used for clinical research, patient registries, safety surveillance, and disease outbreak surveillance. Collecting these data at the point-of-care EHR system, without redundant data entry by physicians and their staff into specialized applications, provides timely and accurate information while minimizing the burden on care providers.

"Sentrx has always been committed to building its drug safety solutions on industry standards," said Joseph Albano, CEO of Sentrx. "The New Directions – Life Sciences Interoperability Demonstration shows how the use of standards in healthcare information technology will ultimately improve patient safety, speed clinical development, and reduce costs for all stakeholders."

The Drug Safety scenario is sponsored by Pfizer and employs the CDISC operational data module (ODM), the International Conference on Harmonization (ICH) E2B standards, and the IHE profile Retrieve Form for Data Capture (RFD) to enable data integration between systems. Implementers include Sentrx, Relsys International, Allscripts, Accenture and SAS. During a physician office visit, a patient describes an adverse event (AE) experienced while using a pharmaceutical product. This information is entered in the patient’s EHR through the physician’s practice system. The appropriate pharmaceutical company’s AE form is located, populated with data already available in the EHR, and presented to the physician for completion. The data is converted to an E2B format for acceptance into the company’s safety system.

HIMSS’07 is taking place February 25 – March 1, 2007, at the Ernest N. Morial Convention Center in New Orleans, LA. The Interoperability Showcase will be located in Booth 7511, and the New Directions – Life Sciences Interoperability Demonstration will be in POD L. For more information on HIMSS, visit www.himss.org.

About Sentrx
Sentrx is a leading provider of technology-enabled solutions and services for global drug safety. Its mission is to help pharmaceutical, biotechnology, medical device, and consumer health companies document the safety profile of their products during clinical development and postapproval, enabling them to minimize risks and maximize benefits. Through its multilingual Safety Response Center, Sentrx delivers a unique combination of highly skilled people, exclusive technology, and best practices in drug safety monitoring. To learn more about Sentrx, please visit their website at www.sentrx.com, or call 1-888-399-8032, extension 261.